A detailed history of Rathbones Group PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Rathbones Group PLC holds 1,207,318 shares of JNJ stock, worth $176 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
1,207,318
Previous 1,237,143 2.41%
Holding current value
$176 Million
Previous $181 Million 8.21%
% of portfolio
1.03%
Previous 1.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $4.34 Million - $4.99 Million
-29,825 Reduced 2.41%
1,207,318 $196 Million
Q2 2024

Aug 09, 2024

SELL
$144.38 - $157.78 $9.71 Million - $10.6 Million
-67,278 Reduced 5.16%
1,237,143 $181 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $1.9 Million - $1.99 Million
-12,256 Reduced 0.93%
1,304,421 $206 Million
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $674,128 - $735,614
4,630 Added 0.35%
1,316,677 $206 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $86.1 Million - $96.5 Million
552,882 Added 72.83%
1,312,047 $204 Million
Q2 2023

Aug 04, 2023

SELL
$154.35 - $166.11 $5.67 Million - $6.1 Million
-36,752 Reduced 4.62%
759,165 $126 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $5.03 Million - $6 Million
33,309 Added 4.37%
795,917 $123 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $650,091 - $729,587
4,058 Added 0.53%
762,608 $135 Million
Q3 2022

Nov 03, 2022

BUY
$161.33 - $179.52 $8.14 Million - $9.06 Million
50,460 Added 7.13%
758,550 $124 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $22.7 Million - $25.1 Million
135,067 Added 23.57%
708,090 $126 Million
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $3.49 Million - $3.97 Million
22,084 Added 4.01%
573,023 $102 Million
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $1.06 Million - $1.17 Million
6,771 Added 1.24%
550,939 $94.2 Million
Q3 2021

Nov 04, 2021

BUY
$161.5 - $179.47 $7.83 Million - $8.7 Million
48,455 Added 9.77%
544,168 $87.9 Million
Q2 2021

Jul 30, 2021

BUY
$159.48 - $171.07 $1.72 Million - $1.85 Million
10,793 Added 2.23%
495,713 $81.7 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $3.39 Million - $3.78 Million
22,174 Added 4.79%
484,920 $79.7 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $1.53 Million - $1.75 Million
11,141 Added 2.47%
462,746 $72.8 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $3.18 Million - $3.49 Million
22,671 Added 5.29%
451,605 $67.2 Million
Q2 2020

Aug 07, 2020

BUY
$128.81 - $155.51 $9.07 Million - $10.9 Million
70,377 Added 19.63%
428,934 $60.3 Million
Q1 2020

May 04, 2020

BUY
$111.14 - $153.99 $6.09 Million - $8.43 Million
54,774 Added 18.03%
358,557 $47 Million
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $124,822 - $143,364
-979 Reduced 0.32%
303,783 $44.3 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $9.46 Million - $10.6 Million
74,542 Added 32.38%
304,762 $39.4 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $25,967 - $28,559
-198 Reduced 0.09%
230,220 $32.1 Million
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $680,648 - $756,823
-5,414 Reduced 2.3%
230,418 $32.2 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $1.27 Million - $1.53 Million
10,341 Added 4.59%
235,832 $30.4 Million
Q3 2018

Oct 12, 2018

BUY
$121.58 - $142.88 $901,880 - $1.06 Million
7,418 Added 3.4%
225,491 $31.2 Million
Q2 2018

Jul 16, 2018

SELL
$119.4 - $131.76 $1.39 Million - $1.53 Million
-11,645 Reduced 5.07%
218,073 $26.5 Million
Q1 2018

Apr 06, 2018

SELL
$125.1 - $148.14 $1.83 Million - $2.16 Million
-14,592 Reduced 5.97%
229,718 $29.4 Million
Q4 2017

Jan 24, 2018

SELL
$131.22 - $143.62 $1.02 Million - $1.12 Million
-7,805 Reduced 3.1%
244,310 $34.1 Million
Q3 2017

Oct 24, 2017

BUY
$129.47 - $135.38 $32.6 Million - $34.1 Million
252,115
252,115 $32.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.